For the quarter ending 2026-03-31, RLYB made $212K in revenue. -$8,295K in net income. Net profit margin of -3912.74%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 212 | 222 | 212 | 212 |
| Research and development | 2,871 | 3,655 | 4,143 | 6,074 |
| General and administrative | 6,074 | 2,979 | 2,994 | 4,195 |
| Total operating expenses | 8,945 | 6,634 | 7,137 | 10,269 |
| Loss from operations | -8,733 | -6,412 | -6,925 | -10,057 |
| Interest income | 201 | 560 | 462 | 523 |
| Other income | 254 | 0 | 22,479 | 118 |
| Total other income, net | 455 | 560 | 22,941 | 641 |
| Loss before equity in losses of joint venture | -8,278 | -5,852 | 16,016 | -9,416 |
| Loss on investment in joint venture | 0 | 0 | 0 | -287 |
| Net loss | -8,278 | -5,852 | 16,016 | -9,703 |
| Net unrealized loss on marketable securities | -17 | -6 | 7 | -30 |
| Other comprehensive loss | -17 | -6 | 7 | -30 |
| Comprehensive loss | -8,295 | -5,858 | 16,023 | -9,733 |
| Basic EPS | -1.46 | 0.052 | 0.36 | -0.22 |
| Diluted EPS | -1.46 | 0.052 | 0.36 | -0.22 |
| Basic Average Shares | 5,688,584 | -112,156,853 | 45,058,591 | 44,841,140 |
| Diluted Average Shares | 5,688,584 | -112,156,853 | 45,058,591 | 44,841,140 |
Rallybio Corp (RLYB)
Rallybio Corp (RLYB)